Announced Fri, 10 Jul · 22:48 IST
HCC appoints Nakul Pasricha as independent director for 5 years
Management Changes View source PDF
HCC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.6%1-day move
₹23.96
prior close
₹23.59
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.4+1.2+1.9+2.0-3.6-2.8-4.2-6.5-4.5-7.8————
Up moveDown movePending
AI summary
HCC has appointed Mr. Nakul Pasricha (DIN: 03176843) as an Additional Non-Executive Independent Director for 5 years effective July 10, 2026, subject to shareholder approval within 3 months. Pasricha is MD and CEO of PharmaSecure with over 27 years of experience across multiple industries and geographies. He is also Co-Promoter of Flexing It, a freelance talent platform. Appointment was made via circular resolution based on NRC recommendation.
Likely market impact
Addition of an experienced independent director strengthens board oversight. No immediate financial impact. Appointment is subject to shareholder approval.